US Patent 9938290 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
Patent 9938290 was granted and assigned to Karus Therapeutics on April, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9938290 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
